Antimicrobial resistance: Action to combat the rising microbial challenges

International Journal of Antimicrobial Agents

Volumn 42, Issue SUPPL.1, 2013, Pages

  Paphitou, Niki I ^a  

^a NICOSIA GENERAL HOSPITAL   (Cyprus)

Author keywords

Action to combat; Antimicrobial resistance; Effectiveness of strategies; Impact

Indexed keywords

ANTIBIOTIC AGENT; AVOPARCIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANIMAL DISEASE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; CAMPYLOBACTER; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EUROPE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MEDICAL PRACTICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; SALMONELLA; STAPHYLOCOCCAL BACTEREMIA; TREND STUDY; VETERINARY MEDICINE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY; HEALTH POLICY; HUMANS; INFECTION CONTROL;

EID: 84879108210     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.04.007     Document Type: Article

References (43)

1. Infectious Diseases Society of America (IDSA), B. Spellberg, M. Blaser, R.J. Guidos, H.W. Boucher, and J.S. Bradley Combating antimicrobial resistance: policy recommendations to save lives Clin Infect Dis 52 Suppl. 5 2011 S397 S428
2. Fleming A. Penicillin's finder assays its future. New York Times 1945 June 26;21.
3. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, and L.B. Rice Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
4. D.M. Shlaes, and R.C. Moellering Jr. The United States Food and Drug Administration and the end of antibiotics Clin Infect Dis 34 2002 420 422
5. S.E. Cosgrove, G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clin Infect Dis 36 2003 53 59
6. C.A. DiazGranados, S.M. Zimmer, M. Klein, and J.A. Jernigan Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis Clin Infect Dis 41 2005 327 333
7. S.E. Cosgrove, K.S. Kaye, G.M. Eliopoulous, and Y. Carmeli Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species Arch Intern Med 162 2002 185 190
8. N.Y. Lee, H.C. Lee, N.Y. Ko, C.M. Chang, H.I. Shih, and C.J. Wu Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia Infect Control Hosp Epidemiol 28 2007 713 719
9. S.E. Cosgrove, Y. Qi, K.S. Kaye, S. Harbarth, A.W. Karchmer, and Y. Carmeli The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges Infect Control Hosp Epidemiol 26 2005 166 174
10. J.J. Engemann, Y. Carmeli, S.E. Cosgrove, V.G. Fowler, M.Z. Bronstein, and S.L. Trivette Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection Clin Infect Dis 36 2003 592 598
11. European Centre for Disease Prevention and Control/European Medicines Agency (ECDC/EMEA) Joint Technical Report. The bacterial challenge - time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. Stockholm, Sweden: EMEA; 2009.
12. E. Balis, A.C. Vatopoulos, M. Kanelopoulou, E. Mainas, G. Hatzoudis, and V. Kontogianni Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli of the normal human gut flora J Clin Microbiol 4 1996 977 988
13. S. Giguère Antimicrobial drug action and interaction: an introduction S. Giguère, J.F. Prescott, J.D. Baggot, R.D. Walker, P.M. Dowling, Antimicrobial therapy in veterinary medicine 2006 Blackwell Publishing Ames, IA 3 10
14. Regulation (EC) No. 1831/2003 of the European Parliament and of The Council of 22 September 2003 on additives for use in animal nutrition. Official Journal of the European Union 2003;L 268/29-43.
15. I. Phillips, M. Casewell, T. Cox, B. De Groot, C. Friis, and R. Jones Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data J Antimicrob Chemother 53 2004 28 52
16. P.S. Mead, L. Slutsker, V. Dietz, L.F. McCaig, J.S. Bresee, and C. Shapiro Food-related illness and death in the United States Emerg Infect Dis 5 1999 607 625
17. H.C. Wegener, F.M. Aarestrup, L.B. Jensen, A.M. Hammerum, and F. Bager Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe Emerg Infect Dis 5 1999 329 335
18. K. Lu, R. Asano, and J. Davies Antimicrobial resistance gene delivery in animal feeds Emerg Infect Dis 10 2004 679 683
19. H.C. Wegener Antibiotics in animal feed and their role in resistance development Curr Opin Microbiol 6 2003 439 445
20. T. Khanna, R. Friendship, C. Dewey, and J. Weese Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers Vet Microbiol 128 2008 298 303
21. I. van Loo, X. Huijsdens, E. Tiemersma, A. de Neeling, N. van de Sande-Bruinsma, and D. Beaujean Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans Emerg Infect Dis 13 2007 1834 1839
22. A.E. van den Bogaard, N. London, C. Driessen, and E.E. Stobberingh Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers J Antimicrob Chemother 47 2001 763 771
23. T.L. Sørensen, M. Blom, D.L. Monnet, N. Frimodt-Møller, R.L. Poulsen, and F. Espersen Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork N Engl J Med 345 2001 1161 1166
24. Communication from the Commission to the European Parliament and the Council. Action plan against the rising threats from antimicrobial resistance. COM (2011) 748 final.
25. World Health Organization (WHO) Regional Office for Europe. European strategic action plan on antibiotic resistance 2011-2016. http://www.euro.who. int/-data/assets/pdf-file/0008/147734/wd14E-AntibioticResistance-111380.pdf [accessed 18.02.13].
26. Council of the European Union. Council conclusions on the impact of antimicrobial resistance in the human health sector and in the veterinary sector - a 'One Health' perspective. May 2012. http://www.consilium.europa.eu/uedocs/ cms-data/docs/pressdata/en/lsa/131126.pdf [accessed 18.02.13].
27. Transatlantic Taskforce on Antimicrobial Resistance. Recommendations for future collaboration between the U.S. and EU. 2011. http://ecdc.europa.eu/en/ activities/diseaseprogrammes/tatfar/documents/210911-tatfar-report.pdf [accessed 18.02.13].
28. Infectious Diseases Society of America The 10 × '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020 Clin Infect Dis 50 2010 1081 1083
29. World Health Organization. Report of the 3rd Meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance, 14-17 June 2011, Oslo, Norway. WHO, 2012.
30. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2009. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; 2010.
31. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; 2011.
32. European Surveillance of Antimicrobial Consumption (ESAC). ESAC yearbook 2009.
33. European Surveillance of Antimicrobial Consumption, ESAC-3: Hospital Care Subproject Group. Report on point prevalence survey of antimicrobial prescribing in European hospitals, 2009.
34. European Medicines Agency. Trends in the sales of veterinary antimicrobial agents in nine European countries. Reporting period: 2005-2009. EMA; 2011. EMA/238630/2011.
35. Special Eurobarometer 338 'Antimicrobial Resistance', 2009. Survey commissioned by the Directorate-General for Health and Consumers and coordinated by the Directorate-General Communication ('Research and Political Analysis' Unit). http://ec.europa.eu/public-opinion/index-fr.htm [accessed 18.02.13].
36. P. Wilton, R. Smith, J. Coast, and M. Millar Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness J Health Serv Res Policy 7 2002 111 117
37. N. van de Sande-Bruinsma, H. Grundmann, D. Verloo, E. Tiemersma, J. Monen, and H. Goossens Antimicrobial drug use and resistance in Europe Emerg Infect Dis 14 2008 1722 1730
38. H. Seppälä, T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, and K. Lager The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance N Engl J Med 337 1997 441 446
39. Anonymous, and Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the French experience Euro Surveill 13 2008 4 9
40. P. Carling, T. Fung, A. Killion, N. Terrin, and M. Barza Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years Infect Control Hosp Epidemiol 24 2003 699 706
41. M.K. Yong, K.L. Buising, A.C. Cheng, and K.A. Thursky Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system J Antimicrob Chemother 65 2010 1062 1069
42. N. Fishman Antimicrobial stewardship Am J Med 119 6 Suppl. 1 2006 S53 S61
43. D.J. Anderson, K.B. Kirkland, K.S. Kaye, P.A. Thacker 2nd, Z.A. Kanafani, and G. Auten Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol 28 2007 767 773